Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9Prostatic Neoplasms, Castration-Resistant 2Urogenital Neoplasms 1Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1Prostatic Diseases 1Neoplasms by Site 1Neoplasms 1Metastatic Castration-resistent Prostate Cancer 1Genital Neoplasms, Male 1Genital Diseases, Male 1Cushing Syndrome 1Adrenocortical Carcinoma 1

Interventions

onapristone 1abiraterone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Genital Diseases, Male × Abiraterone Acetate × Clear all
NCT02049190 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Arno Therapeutics

Phase 1/2 Unknown
75 enrolled
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡